U.N.'s errant prescription for drug access

What's the best way to improve health care for billions of people in the developing world? If you answered, “Attack health care firms,” you qualify for a job with the United Nations.

You'd also be dead wrong.

The U.N. recently released a plan to severely weaken patent protections and other forms of intellectual property (IP). U.N. officials believe that this will bring down the price of medicine in the developing world, thereby improving people's access to drugs.

Their recommendations would do the exact opposite. Dissolving IP protections would disincentivize drug research and slow the discovery of new treatments. Patients in both the developing and developed worlds would be worse off.

Drug development is an enormously expensive endeavor. It costs, on average, $2.6 billion to bring a new medicine to market. Just one out of every 5,000 promising compounds makes it from the lab through clinical trials to the pharmacy shelf. And just two out of every 10 approved drugs ever turn a profit.

 
Sign Up for Our Email Newsletter

RECENT NEWS

Principles for PBM Reform and Patient Centered Prescription Drug Benefits

Principles for PBM Reform and Patient Centered Prescription Drug Benefits

CMPI & NCPA Forum Panel Two discussion: Principles for PBM Reform and Patient Centered Prescription Drug Benefits...  Read more

Keynote Speech: A. Mark Fendrick, M.D.

Keynote Speech: A. Mark Fendrick, M.D.

CMPI & NCPA Forum Keynote Speech: Mark Fendrick, M.D., Director, Center for Value Based Insurance Design, University of M...  Read more

How PBMs Affect Access and Affordability

How PBMs Affect Access and Affordability

CMPI & NCPA Forum Panel One discussion: How PBMs Affect Access and Affordability...  Read more

DRUGWONKS BLOG